Stockreport

CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF still translate into meaningful revenue opportunities thanks to premium pricing, regulatory incentives, and limited competition. Companies operating in this niche often [Read more]